Pharma-backed petition calls on FDA to reform release of drug rejection letters
The FDA for the first time is facing pharma-backed criticism of its new practice of publicly releasing partially redacted drug rejection letters. The law firm Covington & Burling, on behalf of an unnamed pharmaceutical company ...
April 22, 2026 12:14 PM EDTUpdated 03:45 PM FDA+Law Pharma-backed petition calls on FDA to reform release of drug rejection letters Zachary Brennan Senior Editor The FDA for the first time is facing pharma-backed criticism of its new practice of publicly releasing partially redacted drug rejection letters. The law firm … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that